EU Says it has Secured Nearly Half of Pfizer's 2021 Global COVID-19 Vaccine Production
Click the image below to enlarge the infographic.
- The European Union has reached a deal with Pfizer and BioNTech to acquire 300 million additional doses of their COVID-19 vaccine, the head of the European Commission announced Friday
- This move would give the EU nearly half of the firm's global vaccine output for 2021
- Pfizer said it can produce up to 1.3 billion doses this year, and the new agreement with the EU has secured 600 million vaccine doses for the region
- Pfizer has also agreed to sell the US up to 600 million doses of the vaccine, of which 200 million have already been ordered
- Germany also said it will make a side seal with the drug firm to supply 30 million additional doses, in contrast to EU agreements that forbid members to negotiate parallel deals with vaccine makers